Combating chronic T-cell exhaustion

Immunotherapy

Volumn 4, Issue 6, 2012, Pages 557-560

  McAfee, Megan S ^a   Blattman, Joseph N ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

cancer; cytokines; exhaustion; immunotherapy; infection; inhibition; T cell; tolerance

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

CELL AGING, CELL DEGENERATION AND CELL SURVIVAL; CELL FUNCTION; CELL PROLIFERATION; EFFECTOR CELL; EPIGENETICS; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T CELL EXHAUSTION; T LYMPHOCYTE;

ANIMALS; CHRONIC DISEASE; GENE EXPRESSION PROFILING; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNOTHERAPY; INFECTION; NEOPLASMS; T-LYMPHOCYTES;

EID: 84863892832     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.12.46     Document Type: Review

References (39)

1. Rosenberg SA, Yang JC, Sherry RM et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-Cell transfer immunotherapy. Clin. Cancer Res. 17(13), 4550-4557 (2011
2. Einsele H, Hebart H. CMV-Specific immunotherapy. Hum. Immunol. 65(5), 558-564 (2004
3. Van Der Burg SH, Arens R, Melief CJ. Immunotherapy for persistent viral infections and associated disease. Trends Immunol. 32(3), 97-103 (2011
4. Fuller DH, Rajakumar P, Che JW et al. Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-Infected rhesus macaques. PLoS ONE 7(3), e33715 (2012
5. Lang K, Weiner DB. Immunotherapy for HCV infection: Next steps. Expert Rev. Vaccines 7(7), 915-923 (2008
6. Riddell SR, Greenberg PD, Overell RW et al. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-Specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology. Hum. Gene Ther. 3(3), 319-338 (1992
7. Day CL, Kaufmann DE, Kiepiela P et al. PD-1 expression on HIV-Specific T cells is associated with T-Cell exhaustion and disease progression. Nature 443(7109), 350-354 (2006
8. Fourcade J, Sun Z, Benallaoua M et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-Specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207(10), 2175-2186 (2010
9. Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P et al. Tumor-Infiltrating NY-ESO-1-Specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc. Natl Acad. Sci. USA 107(17), 7875-7880 (2010
10. Fourcade J, Sun Z, Pagliano O et al. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72(4), 887-896 (2012
11. Bengsch B, Seigel B, Ruhl M et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-Specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 6(6), e1000947 (2010
12. Yang ZZ, Grote DM, Ziesmer SC et al. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J. Clin. Invest. 122(4), 1271-1282 (2012
13. Butler NS, Moebius J, Pewe LL et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-Stage Plasmodium infection. Nat. Immunol. 13(2), 188-195 (2012
14. Wherry EJ, Blattman JN, Murali-Krishna K, Van Der Most R, Ahmed R. Viral persistence alters CD8 T-Cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77(8), 4911-4927 (2003
15. Kim PS, Ahmed R. Features of responding T cells in cancer and chronic infection. Curr. Opin Immunol. 22(2), 223-230 (2010
16. Ingram JT, Yi JS, Zajac AJ. Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-Infections. PLoS Pathog. 7(9), e1002273 (2011
17. Wherry EJ. T cell exhaustion. Nat. Immunol. 12(6), 492-499 (2011
18. Carroll L. Through the Looking Glass, and What Alice Found There. Macmillian, London, UK (1871
19. Barouch DH, Kunstman J, Glowczwskie J et al. Viral escape from dominant simian immunodeficiency virus epitope-Specific cytotoxic T lymphocytes in DNA-Vaccinated rhesus monkeys. J. Virol. 77(13), 7367-7375 (2003
20. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15(4), 143-146 (2007
21. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-Intrinsic transforming growth factor-Beta signaling mediates virus-Specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31(1), 145-157 (2009
22. Punkosdy GA, Blain M, Glass DD et al. Regulatory T-Cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc. Natl Acad. Sci. USA 108(9), 3677-3682 (2011
23. Schietinger A, Delrow JJ, Basom RS, Blattman JN, Greenberg PD. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 335(6069), 723-727 (2012
24. Youngblood B, Oestreich KJ, Ha SJ et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-Specific CD8(+) T cells. Immunity 35(3), 400-412 (2011
25. Wherry EJ, Ha SJ, Kaech SM et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27(4), 670-684 (2007
26. Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB. IL-10 and PD-L1 operate through distinct pathways to suppress T-Cell activity during persistent viral infection. Proc. Natl Acad. Sci. USA 105(51), 20428-20433 (2008
27. Ejrnaes M, Filippi CM, Martinic MM et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203(11), 2461-2472 (2006
28. Ganapathy V, Ge R, Grazioli A et al. Targeting the transforming growth factor-Beta pathway inhibits human basal-Like breast cancer metastasis. Mol. Cancer 9, 122 (2010
29. Goodnow CC, Sprent J, Fazekas De St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435(7042), 590-597 (2005
30. Blackburn SD, Shin H, Haining WN et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10(1), 29-37 (2009
31. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8(3), 239-245 (2007
32. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ. Tissue-Specific differences in PD-1 and PD-L1 expression during chronic viral infection: IMPLICATIONS for CD8 T-Cell exhaustion. J. Virol. 84(4), 2078-2089 (2010
33. Nakamoto N, Cho H, Shaked A et al. Synergistic reversal of intrahepatic HCV-Specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 5(2), e1000313 (2009
34. Workman CJ, Cauley LS, Kim IJ, Blackman MA, Woodland DL, Vignali DA. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J. Immunol. 172(9), 5450-5455 (2004
35. Jin HT, Anderson AC, Tan WG et al. Cooperation of Tim-3 and PD-1 in CD8 T-Cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 107(33), 14733-14738 (2010
36. Pellegrini M, Calzascia T, Toe JG et al. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144(4), 601-613 (2011
37. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-Cell responses in vivo. Nat. Med. 9(5), 540-547 (2003
38. Teague RM, Sather BD, Sacks JA et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nat. Med. 12(3), 335-341 (2006
39. Dudley ME, Yang JC, Sherry R et al. Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26(32), 5233-5239 (2008)